A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine

• Status: Completed
• Trial end date: 2009-04-01

Summary

The primary objective is to estimate the relative bioavailability of fixed azithromycin / chloroquine combination tablets relative to co-administered individual tablets of azithromycin and chloroquine.

• Phase: Phase 1

Details

• Lead Sponsor: Pfizer
• Treatments: Azithromycin; Chloroquine; Chloroquine diphosphate